Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Teeft.i » - entrée « Azathioprine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Azaspirane compounds < Azathioprine < Azathioprine exposure  Facettes :

List of bibliographic references indexed by Azathioprine

Number of relevant bibliographic references: 113.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
001135 (2013) Prabha Ranganathan [États-Unis]Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
001137 (2013) Claudia Ravaglia [Italie] ; Carlo Gurioli [Italie] ; Gian Luca Casoni [Italie] ; Silvia Asioli [Italie] ; Venerino Poletti [Italie]Fever, splenomegaly and lymphopenia in sarcoidosis
001146 (2013) Inbal Braunstein [États-Unis] ; Victoria Werth [États-Unis]Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy
001188 (2013) Fariz Yahya [Malaisie] ; Raja Jasmin [Malaisie] ; Chin Teck Ng [Malaisie] ; Tien Eang Cheah [Malaisie] ; Sargunan Sockalingam [Malaisie]Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement
001244 (2013) Duygu Emine Ersozlu Bozkirli [Turquie] ; Ilknur Kozanoglu [Turquie] ; Emre Bozkirli [Turquie] ; Eftal Yucel [Turquie]Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis
001326 (2012) H. Ahmadzai ; M. C. Kiernan ; D. Wakefield [Australie] ; P. S. ThomasTreatment of refractory neurosarcoidosis with TNF‐inhibitors: what lies ahead?
001379 (2012) Christina Lam [États-Unis, Canada] ; Ruth Ann Vleugels [États-Unis]Management of cutaneous dermatomyositis
001400 (2012) J. S. Wee [Royaume-Uni] ; P. J. Shirlaw [Royaume-Uni] ; S. J. Challacombe [Royaume-Uni] ; J. F. Setterfield [Royaume-Uni]Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients
001406 (2012) Fiona L. Dignan [Royaume-Uni] ; Persis Amrolia [Royaume-Uni] ; Andrew Clark [Royaume-Uni] ; Jacqueline Cornish [Royaume-Uni] ; Graham Jackson [Royaume-Uni] ; Prem Mahendra [Royaume-Uni] ; Julia J. Scarisbrick [Royaume-Uni] ; Peter C. Taylor [Royaume-Uni] ; Bronwen E. Shaw [Royaume-Uni] ; Michael N. Potter [Royaume-Uni]Diagnosis and management of chronic graft‐versus‐host disease
001409 (2012) Christopher B. Hansen [États-Unis] ; Kevin W. Dahle [États-Unis]Cutaneous lupus erythematosus
001569 (2011) Yiyun Yu [États-Unis, République populaire de Chine] ; Antonio La Cava [États-Unis]Current drugs in systemic lupus erythematosus
001739 (2010) Case Report
001753 (2010) 2.7. Systemic lupus erythematosus, Sjögren's and antiphospholipid syndrome ‐ clinical aspects, comorbidities and complications
001810 (2009) Catherine A. Heyneman [États-Unis]Systemic Lupus Erythematosus: A Therapeutic Update
001818 (2009) F. Goldblatt [Royaume-Uni] ; S. Chambers [Royaume-Uni] ; A. Rahman [Royaume-Uni] ; Da Isenberg [Royaume-Uni]Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality
001959 (2008) S. Bernatsky [Canada] ; L. Joseph [Canada] ; J-F Boivin [Canada] ; C. Gordon [Canada] ; M. Urowitz [États-Unis] ; D. Gladman [États-Unis] ; P R Fortin [États-Unis] ; E. Ginzler [Corée du Sud] ; S-C Bae [Canada] ; S. Barr [Royaume-Uni] ; S. Edworthy [Royaume-Uni] ; D. Isenberg [États-Unis] ; A. Rahman [États-Unis] ; M. Petri [États-Unis] ; G S Alarc N [États-Unis] ; C. Aranow [États-Unis] ; M-A Dooley [Canada] ; R. Rajan [Canada] ; J-L Sénécal [Canada] ; M. Zummer [États-Unis] ; S. Manzi [États-Unis] ; R. Ramsey-Goldman [Canada, Royaume-Uni, États-Unis, Corée du Sud] ; A E Clarke [Canada]The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study
001968 (2008) Robert Kim [États-Unis] ; Keith C. MeyerReview: Therapies for interstitial lung disease: past, present and future
001A08 (2008) A. Delluc [France] ; N. Limal [France] ; X. Puéchal [France] ; C. Francès [France] ; J C Piette [France] ; P. Cacoub [France]Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
001A09 (2008) G. Bertsias [Grèce] ; J P A. Ioannidis [Grèce] ; J. Boletis [Grèce] ; S. Bombardieri [Italie] ; R. Cervera [Espagne] ; C. Dostal [République tchèque] ; J. Font [Espagne] ; I M Gilboe [Norvège] ; F. Houssiau [Belgique] ; T. Huizinga [Pays-Bas] ; D. Isenberg [Royaume-Uni] ; C G M. Kallenberg [Pays-Bas] ; M. Khamashta [Royaume-Uni] ; J C Piette [France] ; M. Schneider [Allemagne] ; J. Smolen [Autriche] ; G. Sturfelt [Suède] ; A. Tincani [Italie] ; R. Van Vollenhoven [Suède] ; C. Gordon [Royaume-Uni] ; D T Boumpas [Grèce]EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
001B71 (2007) Lester E. Mertz [États-Unis] ; Janis E. Blair [États-Unis]Coccidioidomycosis in Rheumatology Patients
001B84 (2007) G. Ruiz-Irastorza [Espagne] ; A. Ugarte [Espagne] ; M V Egurbide [Espagne] ; M. Garmendia [Espagne] ; J I Pijoan [Espagne] ; A. Martinez-Berriotxoa [Espagne] ; C. Aguirre [Espagne]Antimalarials may influence the risk of malignancy in systemic lupus erythematosus
001B89 (2007) S. Chaiamnuay [États-Unis] ; L W Heck [États-Unis] ; W C Bell [États-Unis] ; H M Bastian [États-Unis]Acute granulomatous lupus pneumonitis: the first case report
001C44 (2006) B. Y. H. Thong ; S. Vasoo [Singapour] ; E. T. KohThe use of anti‐tumour necrosis factor‐α therapies for rheumatoid arthritis in Singapore
001C62 (2006) A. Holvast [Pays-Bas] ; A. Huckriede [Pays-Bas] ; J. Wilschut [Pays-Bas] ; G. Horst [Pays-Bas] ; J J C. De Vries [Pays-Bas] ; C A Benne [Pays-Bas] ; C G M. Kallenberg [Pays-Bas] ; M. Bijl [Pays-Bas]Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease
001C81 (2006) James P. Russell [États-Unis] ; Lawrence E. Gibson [États-Unis]Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment
001E51 (2005) Oral presentations
001F33 (2004) J. Kanitakis [France] ; S. Euvrard [France] ; A. C. Butnaru [France] ; A. Claudy [France]Verruciform xanthoma of the scrotum in a renal transplant patient
001F45 (2004) Kam Hon Yoon [Singapour]Successful usage of tacrolimus (FK506) in resistant/relapsed rheumatic diseases
001F51 (2004) Y. Amo [Japon] ; M. Masuzawa [Japon] ; Y. Hamada [Japon] ; K. Katsuoka [Japon]Serum concentrations of vascular endothelial growth factor‐D in angiosarcoma patients
001F53 (2004) G. Dawn [Niger] ; S. C. Holmes [Niger]Scleromyxoedema‐like eruption following haemodialysis or nephrogenic fibrosing dermopathy?
001F61 (2004) P. Fiallo [Italie]Reduced therapeutic activity of warfarin during treatment with oral isotretinoin
001F74 (2004) News and Notices
001F77 (2004) I. Hayashi [Japon] ; T. Harada [Japon] ; M. Muraoka [Japon] ; M. Ishii [Japon]Malignant proliferating trichilemmal tumour and CAV (cisplatin, adriamycin, vindesine) treatment
001F79 (2004) A. Di Carlo [Italie]Lisinopril and Kaposi's sarcoma
001F80 (2004) N. Bilen [Turquie]Lisinopril and Kaposi's sarcoma: reply from authors
001F82 (2004) S. Yashar [États-Unis] ; K. F. Han [États-Unis] ; J. C. Haley [États-Unis]Lichen sclerosus–lichen planus overlap in a patient with hepatitis C virus infection
001F84 (2004) A. Macario-Barrel ; A. Zeghnoun ; P. Young ; L. Froment ; H. Levesque ; F. Caron [France] ; P. Musette ; P. JolyInfluence of environmental temperature on the occurrence of non‐necrotizing cellulitis of the leg
001F92 (2004) Y-J. Deng [République populaire de Chine] ; F. Hao [République populaire de Chine] ; C-L. Zhou [République populaire de Chine] ; R-S. Sun [République populaire de Chine] ; M-M. Xiang [République populaire de Chine] ; J-W. Wang [République populaire de Chine] ; B-Y. Zhong [République populaire de Chine] ; Q-Y. Ye [République populaire de Chine] ; R-Q. Liu [République populaire de Chine]Generalized eruptive histiocytosis: a possible therapeutic cure?
001F95 (2004) G. Herrmann [Allemagne] ; L. Schneider [Allemagne] ; T. Krieg [Allemagne] ; N. Hunzelmann [Allemagne] ; K. Scharffetter-Kochanek [Allemagne]Efficacy of danazol treatment in a patient with the new variant of hereditary angio‐oedema (HAE III)
002002 (2004) Neil H. CoxDermatology – just the facts
002003 (2004) M. E. Kirkup ; E. A. Sheffield ; L. J. Sacks ; J. E. SansomDelayed onset of bullous reaction with severe deep skin necrosis in association with sertraline
002007 (2004) M. T. Gupta ; H. R. JerajaniControl of childhood pemphigus erythematosus with steroids and azathioprine
002011 (2004) British Society for Dermatopathology: Summaries of Papers
002022 (2004) C. Réuena ; L. Requena ; S. Blanco ; C. Álvarez ; C. Galache ; E. RodríguezAcral ulcerations and osteolysis, a severe form of the carpal tunnel syndrome
002028 (2004) K. Tomizawa ; S. Tanaka ; B. Saito ; K. Ota [Japon]A peculiar type of dystrophic calcinosis cutis affecting the surface of damaged genital skin and mucosa in an elderly woman with a vesicovaginal fistula
002029 (2004) P. Rubegni [Italie] ; P. Sbano [Italie] ; M. Risulo [Italie] ; S. Poggiali [Italie] ; M. Fimiani [Italie]A case of reticular erythematous mucinosis treated with topical tacrolimus
002030 (2004) T. Petrella [États-Unis] ; M. A. Teitell [États-Unis] ; C. Spiekermann ; C. J. L. M. Meijer [Pays-Bas] ; F. Franck [France] ; I. Enache [France]A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)
002120 (2003) R. Malik [Australie] ; P. Zunino ; Gb HuntComplete heart block associated with lupus in a dog
002202 (2002) Navaz Hiramanek ; Steven Kossard [Australie] ; Ross Stc BarnetsonMulticentric reticulohistiocytosis presenting with a rash and arthralgia
002231 (2002) Jack B. Cohen [États-Unis]Cutaneous involvement of dermatomyositis can respond to Dapsone therapy
002240 (2002) E N Harris [États-Unis]Antirheumatic drugs in pregnancy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Azathioprine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Azathioprine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Azathioprine
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021